BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24962659)

  • 1. Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness.
    Sevcenco S; Ponhold L; Heinz-Peer G; Fajkovic H; Haitel A; Susani M; Shariat SF; Szarvas T; Baltzer PA
    Urol Oncol; 2014 Nov; 32(8):1166-71. PubMed ID: 24962659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
    Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer.
    Kobayashi S; Koga F; Kajino K; Yoshita S; Ishii C; Tanaka H; Saito K; Masuda H; Fujii Y; Yamada T; Kihara K
    J Magn Reson Imaging; 2014 Jan; 39(1):172-8. PubMed ID: 23589321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis.
    Yamada Y; Kobayashi S; Isoshima S; Arima K; Sakuma H; Sugimura Y
    J Cancer Res Ther; 2014; 10(4):878-82. PubMed ID: 25579522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer.
    Yoshida S; Koga F; Kobayashi S; Ishii C; Tanaka H; Tanaka H; Komai Y; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e21-7. PubMed ID: 22414281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.
    Kobayashi S; Koga F; Yoshida S; Masuda H; Ishii C; Tanaka H; Komai Y; Yokoyama M; Saito K; Fujii Y; Kawakami S; Kihara K
    Eur Radiol; 2011 Oct; 21(10):2178-86. PubMed ID: 21688007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: correlation with pathologic findings.
    Suo ST; Chen XX; Fan Y; Wu LM; Yao QY; Cao MQ; Liu Q; Xu JR
    Acad Radiol; 2014 Aug; 21(8):1027-34. PubMed ID: 24833566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results.
    Rosenkrantz AB; Mussi TC; Spieler B; Melamed J; Taneja SS; Huang WC
    J Magn Reson Imaging; 2012 Jun; 35(6):1478-83. PubMed ID: 22282396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
    Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
    Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results.
    Rosenkrantz AB; Haghighi M; Horn J; Naik M; Hardie AD; Somberg MB; Melamed J; Xiao GQ; Huang WC; Taouli B
    AJR Am J Roentgenol; 2013 Dec; 201(6):1254-9. PubMed ID: 24261364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
    Wang HJ; Pui MH; Guo Y; Li SR; Guan J; Zhang XL; Cai HS
    AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of apparent diffusion coefficient ratio in the diagnosis of bladder cancer grading pre-operation].
    Zhou GX; Wang YB; Hao NX; Wu YW; Zhu JQ; Wang B; Wang ZQ; Tao XF
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(37):2953-6. PubMed ID: 24401582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
    Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
    J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?
    Watanabe H; Kanematsu M; Kondo H; Goshima S; Tsuge Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2009 May; 192(5):1361-6. PubMed ID: 19380561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors.
    Dağgülli M; Onur MR; Fırdolaş F; Onur R; Kocakoç E; Orhan İ
    Urol Int; 2011; 87(3):346-52. PubMed ID: 21934281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
    Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.